Advertisement

Annals of Surgical Oncology

, Volume 14, Issue 2, pp 541–547 | Cite as

Optimal Initial Treatment for Early Hepatocellular Carcinoma in Patients with Preserved Liver Function: Transplantation or Resection?

  • Ronnie T. P. Poon
Article

Abstract

Partial hepatic resection has been the mainstay of curative treatment for hepatocellular carcinoma (HCC) in cirrhotic patients with preserved liver function. Liver transplantation for HCC was initially developed as a treatment option for patients with unresectable tumors associated with Child B or C cirrhosis. However, in recent years, some authors have advocated liver transplantation even for resectable early HCC associated with Child A cirrhosis. Whether transplantation or liver resection is the optimal initial treatment for early HCC in compensated cirrhosis depends on the survival results and also the availability of liver grafts. Recent studies comparing liver resection and transplantation for early HCC in Child A cirrhotic patients demonstrated similar long-term survival. While liver transplantation is associated with a lower tumor recurrence rate, this benefit is counteracted by long-term complications such as immunosuppression related infections and neoplasms. Patients put on transplantation waiting list run a significant risk of tumor progression and dropout, while liver resection is immediately applicable to all. A premature liver transplantation may expose patients to the side effects of immunosuppression earlier than necessary. With the current shortage of liver grafts, advocating primary liver transplantation for patients with early HCC associated with compensated cirrhosis will increase waiting time of transplantation and further increases the chance of dropout. Resection first and salvage transplantation for recurrent tumors or liver failure has been shown to be a feasible strategy in the majority of patients, and this appears to be the optimal strategy with the best use of organs.

Keywords

Cirrhosis Hepatocellular carcinoma Liver resection Transplantation 

References

  1. 1.
    El-Serag HB. Epidemiology of hepatocellular carcinoma. Clin Liver Dis 2001; 5:87–107, viPubMedCrossRefGoogle Scholar
  2. 2.
    Poon RT, Fan ST, Lo CM, et al. Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years. Ann Surg 2001; 234:63–70PubMedCrossRefGoogle Scholar
  3. 3.
    Llovet JM, Schwartz M, Mazzaferro V. Resection and liver transplantation for hepatocellular carcinoma. Semin Liver Dis 2005; 25:181–200PubMedCrossRefGoogle Scholar
  4. 4.
    Schwartz M. Liver transplantation for hepatocellular carcinoma. Gastroenterology 2004; 127(5 Suppl 1):S268–76PubMedCrossRefGoogle Scholar
  5. 5.
    Kurtovic J, Riordan SM, Williams R. Liver transplantation for hepatocellular carcinoma. Best Pract Res Clin Gastroenterol 2005; 19:147–60PubMedCrossRefGoogle Scholar
  6. 6.
    Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334:693–9PubMedCrossRefGoogle Scholar
  7. 7.
    Bigourdan JM, Jaeck D, Meyer N, et al. Small hepatocellular carcinoma in Child A cirrhotic patients: hepatic resection versus transplantation. Liver Transpl 2003; 9:513–20PubMedCrossRefGoogle Scholar
  8. 8.
    Adam R, Azoulay D, Castaing D, et al. Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy? Ann Surg 2003; 238:508–18PubMedCrossRefGoogle Scholar
  9. 9.
    Poon RT, Fan ST, Lo CM, et al. Long-term prognosis after resection of hepatocellular carcinoma associated with hepatitis B-related cirrhosis. J Clin Oncol 2000; 18:1094–101PubMedGoogle Scholar
  10. 10.
    Llovet JM, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 1999; 30:1434–40PubMedCrossRefGoogle Scholar
  11. 11.
    Poon RT, Fan ST, Lo CM, et al. Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation. Ann Surg 2002; 235:373–82PubMedCrossRefGoogle Scholar
  12. 12.
    Cha CH, Ruo L, Fong Y, et al. Resection of hepatocellular carcinoma in patients otherwise eligible for transplantation. Ann Surg 2003; 238:315–21PubMedGoogle Scholar
  13. 13.
    Benckert C, Jonas S, Thelen A, et al. Liver transplantation for hepatocellular carcinoma in cirrhosis: prognostic parameters. Transpl Proc 2005; 37:1693–4CrossRefGoogle Scholar
  14. 14.
    Ravaioli M, Ercolani G, Cescon M, et al. Liver transplantation for hepatocellular carcinoma: further considerations on selection criteria. Liver Transpl 2004; 10:1195–202PubMedCrossRefGoogle Scholar
  15. 15.
    Shabahang M, Franceschi D, Yamashiki N, et al. Comparison of hepatic resection and hepatic transplantation in the treatment of hepatocellular carcinoma among cirrhotic patients. Ann Surg Oncol 2002; 9:881–6PubMedCrossRefGoogle Scholar
  16. 16.
    Margarit C, Escartin A, Castells L, Vargas V, Allende E, Bilbao I. Resection for hepatocellular carcinoma is a good option in Child–Turcotte–Pugh class A patients with cirrhosis who are eligible for liver transplantation. Liver Transpl 2005; 11:1242–51PubMedCrossRefGoogle Scholar
  17. 17.
    Bechstein WO, Guckelberger O, Kling N, et al. Recurrence-free survival after liver transplantation for small hepatocellular carcinoma. Transpl Int 1998; 11(Suppl 1):S189–92PubMedGoogle Scholar
  18. 18.
    Poon RT, Fan ST, Wong J. Risk factors, prevention and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg 2000; 232:10–24CrossRefGoogle Scholar
  19. 19.
    Otto G, Heuschen U, Hofmann WJ, et al. Survival and recurrence after liver transplantation versus liver resection for hepatocellular carcinoma: a retrospective analysis. Ann Surg 1998; 227:424–32PubMedCrossRefGoogle Scholar
  20. 20.
    Figueras J, Jaurrieta E, Valls C, et al. Resection or transplantation for hepatocellular carcinoma in cirrhotic patients: outcomes based on indicated treatment strategy. J Am Coll Surg 2000; 190:580–7PubMedCrossRefGoogle Scholar
  21. 21.
    Poon RT, Fan ST, CM Lo, Liu CL, Wong J. Intrahepatic recurrence after hepatectomy for hepatocellular carcinoma: long-term results of management and prognostic factors. Ann Surg 1999; 229:216–22PubMedCrossRefGoogle Scholar
  22. 22.
    Yao F, Bass NM, Nikolai B, et al. Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list. Liver Transpl 2002; 8:873–83PubMedCrossRefGoogle Scholar
  23. 23.
    Maddala YK, Stadheim L, Andrews JC, et al. Drop-out rates of patients with hepatocellular cancer listed for liver transplantation: outcome with chemoembolization. Liver Transpl 2004; 10:449–55PubMedCrossRefGoogle Scholar
  24. 24.
    Pierie JP, Muzikansky A, Tanabe KK, Ott MJ. The outcome of surgical resection versus assignment to the liver transplant waiting list for hepatocellular carcinoma. Ann Surg Oncol 2005; 12:552–60PubMedCrossRefGoogle Scholar
  25. 25.
    Sharma P, Balan V, Hernandez JL, et al. Liver transplantation for hepatocellular carcinoma: the MELD impact. Liver Transpl 2004; 10:36–41PubMedCrossRefGoogle Scholar
  26. 26.
    Yao FY, Bass NM, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: lessons from the first year under the model of end-stage liver disease (MELD) organ allocation policy. Liver Transpl 2004; 10:621–30PubMedCrossRefGoogle Scholar
  27. 27.
    Gondolesi G, Munoz L, Matsumoto C, et al. Hepatocellular carcinoma: a prime indication for living donor liver transplantation. J Gastrointest Surg 2002; 6:102–7PubMedCrossRefGoogle Scholar
  28. 28.
    Lo CM, Fan ST, Liu CL, et al. The role and limitation of living donor liver transplantation for hepatocellular carcinoma. Liver Transpl 2004; 10:440–7PubMedCrossRefGoogle Scholar
  29. 29.
    Brown RS Jr, Russo MW, Lai M, et al. A survey of liver transplantation from living adult donors in the United States. N Engl J Med 2003; 348:818–25PubMedCrossRefGoogle Scholar
  30. 30.
    Sutcliffe R, Maguire D, Portmann B, Rela M, Heaton N. Selection of patients with hepatocellular carcinoma for liver transplantation. Br J Surg 2005; 93:11–8CrossRefGoogle Scholar
  31. 31.
    Kulik L, Abecassis M. Living donor liver transplantation for hepatocellular carcinoma. Gastroenterology 2004; 127(5 Suppl 1):S277–82PubMedCrossRefGoogle Scholar
  32. 32.
    Poon RT, Fan ST. Resection prior to liver transplantation for hepatocellular carcinoma: a strategy of optimizing the role of resection and transplantation in cirrhotic patients with preserved liver function. Liver Transpl 2004; 10:813–5PubMedCrossRefGoogle Scholar
  33. 33.
    Hu RH, Ho MC, Wu YM, Yu SC, Lee PH. Feasibility of salvage liver transplantation for patients with recurrent hepatocellular carcinoma. Clin Transpl 2005; 19:175–80CrossRefGoogle Scholar
  34. 34.
    Majno P, Mentha G, Mazzaferro V. Resection, transplantation, either, or both? Other pieces of the puzzle. Liver Transpl 2005; 11:1177–80PubMedCrossRefGoogle Scholar
  35. 35.
    Belghiti J, Cortes A, Abdalla EK, et al. Resection prior to liver transplantation for hepatocellular carcinoma. Ann Surg 2003; 238:885–93PubMedCrossRefGoogle Scholar
  36. 36.
    Poon RT, Fan ST. Is primary resection and salvage transplantation for hepatocellular carcinoma a reasonable strategy? Ann Surg 2004; 240:925–8PubMedCrossRefGoogle Scholar
  37. 37.
    Sala M, Fuster J, Llovet JM, et al. High pathological risk of recurrence after surgical resection for hepatocellular carcinoma. An indication for salvage transplantation. Liver Transpl 2004; 10:1294–300PubMedCrossRefGoogle Scholar
  38. 38.
    Graziadei IW, Sandmueller H, Waldenberger P, et al. Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on waiting list and leads to excellent outcome. Liver Transpl 2003; 9:557–63PubMedCrossRefGoogle Scholar
  39. 39.
    Decaens T, Roudot-Thoraval F, Bresson-Hadni S, et al. Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma. Liver Transpl 2005; 11:767–75PubMedCrossRefGoogle Scholar
  40. 40.
    Ravaioli M, Grazi GL, Ercolani G, et al. Partial necrosis on hepatocellular carcinoma nodules facilitates tumor recurrence after liver transplantation. Transplantation 2004; 78:1780–6PubMedCrossRefGoogle Scholar
  41. 41.
    Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC. Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or =4 cm. Gastroenterology 2004; 127:1714–23PubMedCrossRefGoogle Scholar
  42. 42.
    Shiina S, Teratani T, Obi S, et al. A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology 2005; 129:122–30PubMedCrossRefGoogle Scholar
  43. 43.
    Fontana RJ, Hamidullah H, Nghiem H, et al. Percutaneous radiofrequency thermal ablation of hepatocellular carcinoma: a safe and effective bridge to liver transplantation. Liver Transpl 2002; 8:1165–74PubMedCrossRefGoogle Scholar
  44. 44.
    Wong LL, Tanaka K, Lau L, Komura S. Pre-transplant treatment of hepatocellular carcinoma: assessment of tumor necrosis in explanted livers. Clin Transpl 2004; 18:227–34CrossRefGoogle Scholar
  45. 45.
    Llovet JM, Vilana R, Bru C, et al. Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology 2001; 33:1124–9PubMedCrossRefGoogle Scholar
  46. 46.
    De Baere T, Risse O, Kuoch V, et al. Adverse events during radiofrequency treatment of 582 hepatic tumors. AJR Am J Roentgenol 2003; 181:695–700PubMedGoogle Scholar
  47. 47.
    Poon RT, Ng KK, Lam CM, et al. Radiofrequency ablation for subcapsular hepatocellular carcinoma. Ann Surg Oncol 2004; 11:281–9PubMedCrossRefGoogle Scholar

Copyright information

© Society of Surgical Oncology 2006

Authors and Affiliations

  1. 1.Centre for the Study of Liver Disease, Department of SurgeryThe University of Hong Kong, Queen Mary HospitalHong KongChina

Personalised recommendations